Cite

HARVARD Citation

    Bauer, T. et al. (n.d.). 428PInterim results from a phase I trial of SL-801: A novel XPO-1 inhibitor, in patients with advanced solid tumors. Annals of oncology. p. . [Online]. 
  
Back to record